financetom
Business
financetom
/
Business
/
Conduent Q2 revenue misses estimates; adjusted EBITDA rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Conduent Q2 revenue misses estimates; adjusted EBITDA rises
Aug 6, 2025 5:36 AM

Overview

* Conduent ( CNDT ) Q2 revenue fell 8.9% yr/yr, missing analyst expectations

* Adjusted EPS for Q2 beat estimates, showing a 7.1% improvement

* Adjusted EBITDA margin rose to 4.9% from 3.1%, indicating improved efficiency

Outlook

* Conduent ( CNDT ) expects FY 2025 adjusted revenue of $3.1 bln to $3.2 bln

* Company anticipates FY 2025 adjusted EBITDA margin of 5.0% to 5.5%

* Government decisions may unlock opportunities for Government segment

Result Drivers

* DIVESTITURES - Revenue decline attributed to divestiture-driven gains from BenefitWallet and Curbside Management sales

* TRANSPORTATION SEGMENT - Investments in technology platforms accelerated performance in Transportation segment

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 $754 mln

Revenue

Q2 Miss $754 mln $763.70

Adjusted mln (3

Revenue Analysts

)

Q2 Beat -$0.13 -$0.14

Adjusted (2

EPS Analysts

)

Q2 EPS -$0.26

Q2 Net -$40 mln

Income

Q2 $37 mln

Adjusted

EBITDA

Q2 4.9%

Adjusted

EBITDA

Margin

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Astronics Q3 sales miss estimates
Astronics Q3 sales miss estimates
Nov 4, 2025
Overview * Astronics ( ATRO ) Q3 sales up 3.8% to $211.4 mln, missing analyst expectations * Company reports Q3 net loss of $11.1 mln due to refinancing-related charges * Adjusted EBITDA for Q3 was $32.7 mln, or 15.5% of sales Outlook * Company expects Q4 revenue between $225 mln and $235 mln * Astronics ( ATRO ) sees 2025...
Niagen Bioscience Q3 sales beat estimates on strong e-commerce performance 
Niagen Bioscience Q3 sales beat estimates on strong e-commerce performance 
Nov 4, 2025
Overview * Niagen Bioscience ( NAGE ) Q3 net sales rise 33%, beating analyst expectations * Adjusted EBITDA for Q3 increases 120%, reflecting improved operational performance * Company reaffirms full-year net sales growth outlook of 25% to 30% Outlook * Niagen Bioscience ( NAGE ) reaffirms 2025 net sales growth of 25% to 30% y-o-y * Company expects 2025 gross...
Healthcare firm Personalis beats Q3 revenue estimates 
Healthcare firm Personalis beats Q3 revenue estimates 
Nov 4, 2025
Overview * Personalis ( PSNL ) Q3 revenue beats analyst expectations despite a 44% yr/yr decline * Net loss for Q3 2025 was $21.7 mln, compared to $39.1 mln last year * Clinical test volume grows 364% yr/yr, driven by NeXT Personal platform adoption Outlook * Personalis expects Q4 2025 revenue between $15.7 mln and $20.7 mln * Full-year 2025...
Equitable Holdings Q3 EPS misses estimates
Equitable Holdings Q3 EPS misses estimates
Nov 4, 2025
Overview * Equitable Holdings ( EQH ) reports Q3 net loss of $1.3 bln due to life reinsurance impact * Adjusted EPS for Q3 misses analyst expectations * Assets under management rose 7% yr/yr to $1.1 trillion Outlook * Equitable Holdings ( EQH ) maintains confidence in achieving 2027 financial targets * Company plans $1.5 bln capital deployment for growth...
Copyright 2023-2026 - www.financetom.com All Rights Reserved